REQUEST A DEMO
Total
USD $0.00
Search more companies

Procareplus Pharma S.A. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Medical Equipment and Supplies Manufacturing | All Other Miscellaneous Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | Pharmacies and Drug Stores | Department Stores | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Procareplus Pharma S.A. Profile Updated: December 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Procareplus Pharma S.A is a pharmaceutical company that develops a wide range of medicines and dietary supplements with proven clinical value, including products like Ferrosil ProCarePlus and InsudiabPLUS. Procareplus Pharma is expanding its product portfolio with prescription and non-prescription drugs, and is currently emphasizing online sales and building partnerships with pharmaceutical networks and retail stores.

Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Procareplus Pharma S.A. report to view the information.

Website: http://www.pcppharma.pl

Basic Information
Outstanding Shares:
Purchase the Procareplus Pharma S.A. report to view the information.
Registered Capital:
Purchase the Procareplus Pharma S.A. report to view the information.
Financial Auditors:
Purchase the Procareplus Pharma S.A. report to view the information.
Incorporation Date:
January 24, 2020
Key Executives
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Procareplus Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-51.58%
Total operating revenue
-52.59%
Operating profit (EBIT)
59.51%
Net Profit (Loss) for the Period
55.19%
Total assets
-97.41%
Total equity
N/A
Operating Profit Margin (ROS)
60.37%
Net Profit Margin
25%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-1.18%
Cash Ratio
-0.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?